These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12529809)

  • 1. Pentagastrin test for anxiety--psychophysiology and personality.
    Radu D; Ahlin A; Svanborg P; Lindefors N
    Psychopharmacology (Berl); 2003 Mar; 166(2):139-45. PubMed ID: 12529809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels.
    Radu D; Ahlin A; Svanborg P; Lindefors N
    Psychopharmacology (Berl); 2002 Jun; 161(4):396-403. PubMed ID: 12073167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of central administration of the CCK-B receptor agonist pentagastrin on feeding and cortisol release in sheep.
    Ebenezer IS; Parrott RF
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):235-8. PubMed ID: 8803955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD; Slate SO; Geraci M; Uhde TW
    Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
    Abelson JL; Liberzon I
    Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol on symptom and endocrine responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychoneuroendocrinology; 2004 Oct; 29(9):1163-71. PubMed ID: 15219640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and respiratory responses to a panicogenic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle.
    Brack KE; Jeffery SM; Lovick TA
    Eur J Neurosci; 2006 Jun; 23(12):3309-18. PubMed ID: 16820020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response of arginine vasopressin to the CCK-B agonist pentagastrin.
    Abelson JL; Le Mellédo J; Bichet DG
    Neuropsychopharmacology; 2001 Feb; 24(2):161-9. PubMed ID: 11120398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260.
    Lines C; Challenor J; Traub M
    Br J Clin Pharmacol; 1995 Mar; 39(3):235-42. PubMed ID: 7619662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.
    Coupland N; Zedkova L; Sanghera G; Leyton M; Le Mellédo JM
    J Psychiatry Neurosci; 2001 May; 26(3):247-51. PubMed ID: 11394194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin- and gastrin-induced protein and amylase secretion from the parotid gland of the anaesthetized rat.
    Aras HC; Ekström J
    Regul Pept; 2006 May; 134(2-3):89-96. PubMed ID: 16515811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychiatry Res; 2004 May; 126(3):189-95. PubMed ID: 15157745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
    J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentagastrin-induced protein synthesis in the parotid gland of the anaesthetized rat, and its dependence on CCK-A and -B receptors and nitric oxide generation.
    Cevik Aras H; Ekström J
    Exp Physiol; 2006 Jul; 91(4):673-9. PubMed ID: 16556659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety.
    Rezayat M; Roohbakhsh A; Zarrindast MR; Massoudi R; Djahanguiri B
    Physiol Behav; 2005 Apr; 84(5):775-82. PubMed ID: 15885255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
    Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
    Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between respiratory, endocrine, and cognitive-emotional factors in response to a pharmacological panicogen.
    Lyubkin M; Giardino ND; Abelson JL
    Depress Anxiety; 2010 Nov; 27(11):1011-6. PubMed ID: 20721903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.